JPH07507771A - N−置換アザビシクロヘプタン−誘導体,その製造および使用 - Google Patents
N−置換アザビシクロヘプタン−誘導体,その製造および使用Info
- Publication number
- JPH07507771A JPH07507771A JP5517817A JP51781793A JPH07507771A JP H07507771 A JPH07507771 A JP H07507771A JP 5517817 A JP5517817 A JP 5517817A JP 51781793 A JP51781793 A JP 51781793A JP H07507771 A JPH07507771 A JP H07507771A
- Authority
- JP
- Japan
- Prior art keywords
- exo
- phenyl
- azabicyclo
- group
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (2)
- 1.式I: ▲数式、化学式、表等があります▲I、[式中、 R1は水素原子またはハロゲン原子、C1〜C4アルキル、トリフルオロメチル −、ヒドロキシ−、C1〜C4アルコキシ−、アミノ−、モノメチルアミノ−、 ジメチルアミノ−、シアノ−またはニトロ基で1箇所または2箇所置換されてい てもよいフェニル−、ピリジル−、チェニル−またはピロロ基を表し、 R2は水素原子またはハロゲン、メトキシ、ヒドロキシまたはアミノで置換され ていてもよいフェニル基を表し、 nは0、1、2、3または4を表し、 R3は水素原子、ヒドロキシ−、C1〜C4アルキル−またはC1〜C4アルコ キシ基を表すか、または隣接する炭素原子と一緒になってC=OまたはC=S基 を表し、 XおよびYは炭素原子、CH−、CH2−、NH−またはC1〜C4アルキル− N−基または窒素原子を表し、 Zは直接結合、CO基、CS基またはCH−もしくはCH2基を表し、その際、 1個の水素原子はヒドロキシ−、アミノ−またはC1〜C4アルコキシ基または ハロゲン原子に置換えられていてもよく、および Aは水素原子、ヒドロキシ−、アミノ−、メルカプト−、C1〜C4アルキルア ミノ−、ジ−C1〜C4アルキルアミノ−、C1〜C4アルキルチオ−またはC 1〜C4アルコキシ基を表すか、または隣接する炭素原子と一緒になって、C= O基を表し、またはAはYと結合するC3〜C4アルキル基を表し、この基は1 個または2個の連接しない二重結合を有していることができ、その際、1個のC H−またはCH2基は1個の窒素原子または硫黄原子またはNH−またはN−C H3基で置換えられていてもよく、その際、この環はフッ素原子はたは塩素原子 またはメチル−、メトキシ−、ニトロ−またはアミノ基により1箇所置換れてい ることができるかまたはこの環がベンゼン環の場合には、フッ素原子または塩素 原子またはメチル−、トリフルオロメチル−、ニトロ−、ヒドロキシ−、メトキ シ−、アミノ−、モノメチル−またはジメチルアミノ基により1箇所または2箇 所または3箇所置換されていることができ、その際、式Iの右側部分において、 番号1の窒素原子が、C1〜C4アルキル−、アリル−またはベンジル基を有す ることができ、および1〜3個の連接しない二重結を有することができる〕で示 されるN−置換3−アザビシクロ[3,2,0]ヘプタン−誘導体およびその生 理学的に認容性の酸との塩。
- 2.疾患に対抗する際に使用するための請求項1記載の式Iの化合物。
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4219974 | 1992-06-19 | ||
DE4243287.1 | 1992-12-21 | ||
DE4243287A DE4243287A1 (de) | 1992-06-19 | 1992-12-21 | N-Substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung |
DE4219974.3 | 1992-12-21 | ||
PCT/EP1993/001438 WO1994000458A1 (de) | 1992-06-19 | 1993-06-08 | N-substituierte 3-azabicyclo[3.2.0]heptanderivate als neuroleptika usw. |
CN93114691A CN1039996C (zh) | 1992-06-19 | 1993-12-11 | N-取代氮杂双环庚烷衍生物及其用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH07507771A true JPH07507771A (ja) | 1995-08-31 |
JP3171258B2 JP3171258B2 (ja) | 2001-05-28 |
Family
ID=36940125
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP51781793A Expired - Fee Related JP3171258B2 (ja) | 1992-06-19 | 1993-06-08 | N−置換アザビシクロヘプタン−誘導体,その製造および使用 |
Country Status (24)
Country | Link |
---|---|
US (1) | US5475105A (ja) |
EP (1) | EP0647231B1 (ja) |
JP (1) | JP3171258B2 (ja) |
CN (2) | CN1042133C (ja) |
AT (1) | ATE157366T1 (ja) |
AU (1) | AU671130B2 (ja) |
BG (1) | BG62350B2 (ja) |
CA (1) | CA2138289C (ja) |
CZ (1) | CZ288787B6 (ja) |
DE (2) | DE4243287A1 (ja) |
DK (1) | DK0647231T3 (ja) |
ES (1) | ES2107035T3 (ja) |
FI (1) | FI108726B (ja) |
GR (1) | GR3025095T3 (ja) |
HU (1) | HU218911B (ja) |
IL (1) | IL105989A (ja) |
NO (1) | NO305176B1 (ja) |
NZ (1) | NZ253121A (ja) |
PH (1) | PH30466A (ja) |
RU (1) | RU2135503C1 (ja) |
SG (1) | SG44782A1 (ja) |
TW (1) | TW408126B (ja) |
WO (1) | WO1994000458A1 (ja) |
ZA (1) | ZA934374B (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008516912A (ja) * | 2004-10-14 | 2008-05-22 | アボット ゲーエムベーハー ウント カンパニー カーゲー | ドーパミンd3受容体の調節に応答する障害の治療に好適なアザビシクロヘプチル化合物 |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4427648A1 (de) * | 1994-08-04 | 1996-02-08 | Basf Ag | N-Stubstituierte 3-Azabicyclo[3,2,0,]heptan-Derivate, ihre Herstellung und Verwendung |
DE4338396A1 (de) * | 1993-11-10 | 1995-05-11 | Basf Ag | N-Substituierte Azabicycloalkan-Derivate, ihre Herstellung und Verwendung |
DE4341402A1 (de) * | 1993-12-04 | 1995-06-08 | Basf Ag | N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung |
DE4341403A1 (de) * | 1993-12-04 | 1995-06-08 | Basf Ag | N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung |
DE4427647A1 (de) * | 1994-08-04 | 1996-02-08 | Basf Ag | N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung |
US5929080A (en) * | 1997-05-06 | 1999-07-27 | American Cyanamid Company | Method of treating polycystic kidney disease |
US6323209B1 (en) | 1997-11-06 | 2001-11-27 | American Cyanamid Company | Method of treating or inhibiting colonic polyps |
US6458821B1 (en) * | 1998-08-12 | 2002-10-01 | Abbott Laboratories | N-substituted azabicycloheptane derivatives, production and use thereof |
DE19836406A1 (de) | 1998-08-12 | 2000-02-17 | Basf Ag | N-Substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung |
DE19836404A1 (de) * | 1998-08-12 | 2000-02-17 | Basf Ag | N-Substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung |
DE19848521A1 (de) * | 1998-10-21 | 2000-04-27 | Basf Ag | Verfahren zur Herstellung von (+)-exo-6-Phenyl-3-azabicyclo-[3.2.0]heptanen |
DE19960074A1 (de) * | 1999-12-13 | 2001-06-21 | Basf Ag | Neues Salz von Belaperidone und dessen Modifikationen |
WO2002014295A1 (en) * | 2000-08-16 | 2002-02-21 | Elena Alexandrovna Izakson | Thiazine derivatives having antibacterial and antiviral action |
US20060199768A1 (en) * | 2005-03-07 | 2006-09-07 | University Of North Carolina At Chapel Hill | Inhibitors of RecA activities for control of antibiotic-resistant bacterial pathogens |
CA2670116C (en) | 2006-11-22 | 2015-03-10 | Seaside Therapeutics, Llc | Methods of treating mental retardation, down's syndrome, fragile x syndrome and autism |
NZ583487A (en) * | 2007-07-27 | 2011-09-30 | Actelion Pharmaceuticals Ltd | 2-aza-bicyclo[3.3.0]octane derivatives |
EP3186242B1 (en) * | 2014-08-29 | 2021-10-06 | Tes Pharma S.r.l. | Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase |
CN112010851A (zh) * | 2020-06-30 | 2020-12-01 | 浙江美诺华药物化学有限公司 | 一种莫西沙星盐酸盐的制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3155668A (en) * | 1960-04-11 | 1964-11-03 | Sterling Drug Inc | 1-[3-, 2-, and 1-indolyl)-lower-alkyl]-tertiary amines and intermediates therefor |
US3328390A (en) * | 1962-02-27 | 1967-06-27 | Tri Kem Corp | Certain azabicycloalkane compounds |
US4443451A (en) * | 1981-07-15 | 1984-04-17 | Janssen Pharmaceutica N.V. | Bicyclic pyrimidin-5-one derivatives |
DE3228303A1 (de) * | 1982-07-29 | 1984-02-02 | Robert Bosch Gmbh, 7000 Stuttgart | Elektrische motorregelung |
US4540318A (en) * | 1982-07-29 | 1985-09-10 | Robert Bosch, Gmbh | Rotary electrical tool with speed control, especially drill |
US4605655A (en) * | 1984-03-06 | 1986-08-12 | Bristol-Myers Company | Antipsychotic 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine derivatives |
US4804663A (en) * | 1985-03-27 | 1989-02-14 | Janssen Pharmaceutica N.V. | 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
-
1992
- 1992-12-21 DE DE4243287A patent/DE4243287A1/de not_active Withdrawn
-
1993
- 1993-06-08 AT AT93912910T patent/ATE157366T1/de not_active IP Right Cessation
- 1993-06-08 WO PCT/EP1993/001438 patent/WO1994000458A1/de active IP Right Grant
- 1993-06-08 CZ CZ19943237A patent/CZ288787B6/cs not_active IP Right Cessation
- 1993-06-08 SG SG1996007476A patent/SG44782A1/en unknown
- 1993-06-08 RU RU95105435/04A patent/RU2135503C1/ru not_active IP Right Cessation
- 1993-06-08 CA CA002138289A patent/CA2138289C/en not_active Expired - Fee Related
- 1993-06-08 ES ES93912910T patent/ES2107035T3/es not_active Expired - Lifetime
- 1993-06-08 EP EP93912910A patent/EP0647231B1/de not_active Expired - Lifetime
- 1993-06-08 DK DK93912910.2T patent/DK0647231T3/da active
- 1993-06-08 DE DE59307217T patent/DE59307217D1/de not_active Expired - Fee Related
- 1993-06-08 HU HU9403641A patent/HU218911B/hu not_active IP Right Cessation
- 1993-06-08 US US08/356,178 patent/US5475105A/en not_active Expired - Lifetime
- 1993-06-08 NZ NZ253121A patent/NZ253121A/en unknown
- 1993-06-08 AU AU43238/93A patent/AU671130B2/en not_active Ceased
- 1993-06-08 JP JP51781793A patent/JP3171258B2/ja not_active Expired - Fee Related
- 1993-06-11 IL IL10598993A patent/IL105989A/xx not_active IP Right Cessation
- 1993-06-18 ZA ZA934374A patent/ZA934374B/xx unknown
- 1993-06-19 CN CN93109449A patent/CN1042133C/zh not_active Expired - Fee Related
- 1993-12-11 CN CN93114691A patent/CN1039996C/zh not_active Expired - Fee Related
- 1993-12-14 TW TW082110584A patent/TW408126B/zh not_active IP Right Cessation
-
1994
- 1994-02-14 PH PH47479A patent/PH30466A/en unknown
- 1994-02-28 BG BG98600A patent/BG62350B2/bg unknown
- 1994-12-16 NO NO944892A patent/NO305176B1/no not_active IP Right Cessation
- 1994-12-19 FI FI945957A patent/FI108726B/fi active
-
1997
- 1997-10-20 GR GR970402736T patent/GR3025095T3/el unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008516912A (ja) * | 2004-10-14 | 2008-05-22 | アボット ゲーエムベーハー ウント カンパニー カーゲー | ドーパミンd3受容体の調節に応答する障害の治療に好適なアザビシクロヘプチル化合物 |
JP4754570B2 (ja) * | 2004-10-14 | 2011-08-24 | アボット ゲーエムベーハー ウント カンパニー カーゲー | ドーパミンd3受容体の調節に応答する障害の治療に好適なアザビシクロヘプチル化合物 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH07507771A (ja) | N−置換アザビシクロヘプタン−誘導体,その製造および使用 | |
AU2015341177B2 (en) | Six-membered ring benzo derivatives as DPP-4 inhibitor and use thereof | |
JPS6084282A (ja) | 1−ヘテロアリ−ル−4−〔(2.5−ピロリジンジオン−1−イル)アルキル〕ピペラジン誘導体 | |
FI95259B (fi) | Menetelmä farmaseuttisesti aktiivisten 7-substituoitu-2-amino-3,5-dihydro-4H-pyrrolo/3,2-d/pyrimidin-4-onien valmistamiseksi | |
BG63633B1 (bg) | N-заместени 3-азабицикло(3.2.0) хептанови производни, метод за получаване и използването им | |
FR2930249A1 (fr) | Nouveaux derives de 3-aminoalkyl-1,3-dihydro-2h-indol-2-one, leur preparation et leur application en therapeutique. | |
JP3171261B2 (ja) | 神経弛緩薬等としてのn−置換された3−アザビシクロ[3.2.0]ヘプタン誘導体 | |
WO2015093534A1 (ja) | 置換トリアジノン化合物及びt型カルシウムチャネル阻害剤 | |
BG63632B1 (bg) | N-заместени азабициклохептанови производни, приложими като невролептици | |
JP2015508089A (ja) | 置換ピラゾロ[1,5−a]ピリジン、その製造方法及び薬剤としての使用 | |
US10519105B2 (en) | KCNQ2-5 channel activator | |
KR100254665B1 (ko) | 신경이완제 등으로서 유용한 n-치환된 3-아자비시클로(3.2.0)헵탄 유도체 | |
FR2601364A1 (fr) | Nouveaux derives de la piperazine dione-2,6, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. | |
TW393482B (en) | N-substituted 3-azabicyclo[3.2.0]heptane derivatives, the preparation and use thereof | |
RU2120439C1 (ru) | N-замещенные производные 3-азабицикло(3,2,0)-гептана и их соли с физиологически переносимыми кислотами | |
SI9300625A (sl) | N-substituirani derivati azabicikloheptana, njihova priprava in uporaba | |
MX2007012242A (es) | Ciclohexan-1,4-diaminas sustituidas con piperacinilo. | |
EP1105388B1 (de) | N-substituierte azabicycloheptan-derivate, ihre herstellung und verwendung | |
HRP931499A2 (en) | N-substituted azabicycloheptane derivatives, their production and use | |
NZ250371A (en) | N-substituted-3-azabicyclo[3.2.0]heptane derivatives, preparation and pharmaceutical compositions thereof | |
JPS6226282A (ja) | ヒダントイン誘導体およびその製法ならびにそれを含有する医薬 | |
NO180192B (no) | N-substituerte azabicykloheptanderivater og anvendelse derav |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080323 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090323 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090323 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100323 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100323 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110323 Year of fee payment: 10 |
|
LAPS | Cancellation because of no payment of annual fees |